Clinical Trial Update: Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal Metastasis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating intraperitoneal paclitaxel with XELOX in gastric cancer with peritoneal metastasis; current status not disclosed on the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Metastasis
• Stomach Neoplasms

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Stomach Neoplasms, Paclitaxel | Phase 1, Phase 2 | Status: UNKNOWN